Our Story
Better Lives for Patients Living with Duchenne Muscular Dystrophy
StrongHolt Therapeutics is a biotechnology company driven to find a cure for Duchenne muscular dystrophy (DMD)
Our Mission
Our mission is to deliver life-changing therapies to patients with DMD.
Our lead candidate SH-0322 has demonstrated superior safety and efficacy in preclinical models, significantly outperforming current treatments in development or currently FDA-approved.
Join us on our journey to redefine the future of DMD treatment.